Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Lijun International Pharma Reports Strong First-Half

publication date: Jul 17, 2009
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Lijun International Pharmaceutical (Holding) Co. and its subsidiaries expect their six months’ profit for 2009 to be roughly equal to the net income for the entire year 2008. Lijun earned HK$102,106,000 ($13.2 million) last year. Mr. Wu Qin, Chairman of Lijun International, said stable prices combined with growth in the domestic pharmaceutical market translated to an increase in gross profit margins. More details...

Stock Symbol: (HKEX: 2005)

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...